EDGEWELL PERSONAL CARE Co

Previous wording

Retail sales for purposes of market size, market position and market share information are based on retail sales in U.S. dollars.

Current wording

Retail sales for purposes of market size, market position and market share information are based on measured retail sales in United States dollars.

Previous wording

On February 2, 2026, we closed the transaction and received proceeds of approximately $340 on a cash-free and debt-free basis. In connection with closing of the transaction, we and Essity entered into a transition services agreement for the provision of certain services to support the transition of the Feminine Care segment following the closing. The divestiture of the Feminine Care segment is a key step to transform Edgewell into a more focused, agile and consumer-driven personal care company. The former Feminine Care segment’s results are presented as discontinued operations on a retrospective basis for the three and six months period ended March 31, 2026 and 2025.

Current wording

On February 2, 2026, we closed the transaction and received proceeds of approximately $340 on a cash-free and debt-free basis. In connection with closing of the transaction, we and Essity entered into a transition services agreement for the provision of certain services to support the transition of the Feminine Care segment following the closing. The divestiture of the Feminine Care segment is a key step to transform Edgewell into a more focused, agile and consumer-driven personal care company. The former Feminine Care segment’s results are presented as discontinued operations on a retrospective basis for the three and nine months ended June 30, 2026 and 2025.

Previous wording

The following is a summary of results from continuing operations for the second quarter of fiscal 2026, as compared to the corresponding period in fiscal 2025. In addition to net sales, net income from continuing operations and earnings per share (“EPS”) from continuing operations for the periods presented were also impacted by certain costs or income, as described in the table below. The impact of these items on reported net income from continuing operations and EPS from continuing operations are provided as a reconciliation of net income from continuing operations and EPS from continuing operations to adjusted net income from continuing operations and adjusted diluted EPS from continuing operations, both of which are non-GAAP measures.

Current wording

The following is a summary of results from continuing operations for the third quarter and first nine months of fiscal 2026, as compared to the corresponding periods in fiscal 2025. In addition to net sales, net earnings (loss) from continuing operations and earnings per share (“EPS”) from continuing operations for the periods presented were also impacted by certain costs or income, as described in the table below. The impact of these items on reported net earnings (loss) from continuing operations and EPS from continuing operations are provided as a reconciliation of net earnings (loss) from continuing operations and EPS from continuing operations to adjusted net earnings from continuing operations and adjusted diluted EPS from continuing operations, both of which are non-GAAP measures.

Previous wording

•Net earnings from continuing operations in the second quarter of fiscal 2026 were $4.0, as compared to $20.8 in the prior year quarter. On an adjusted basis, net earnings from continuing operations for the second quarter of fiscal 2026 were $27.8, as compared to $32.9 in the prior year quarter. Adjusted net earnings decreased primarily due to lower gross profit and higher operating expenses, partially offset by higher sales and lower interest expense.

Current wording

•Net earnings from continuing operations in the third quarter of fiscal 2026 were $12.3 compared to $21.5 in the prior year quarter. On an adjusted basis, net earnings from continuing operations for the third quarter of fiscal 2026 were $33.5 compared to $33.6 in the prior year quarter. Adjusted net earnings decreased primarily due to lower gross margin and higher operating expenses.

Previous wording

•Diluted net earnings per share from continuing operations during the second quarter of fiscal 2026 were $0.09, as compared to $0.43 in the prior year quarter. On an adjusted basis, diluted net earnings per share from continuing operations during the second quarter of fiscal 2026 were $0.60, as compared to $0.69 in the prior year quarter.

Current wording

•Diluted net earnings per share from continuing operations during the third quarter of fiscal 2026 were $0.26 compared to $0.46 in the prior year quarter. On an adjusted basis, diluted net earnings from continuing operations per share during the third quarter of fiscal 2026 were $0.72 compared to $0.72 in the prior year quarter.

Previous wording

For the first six months of fiscal 2026, net sales increased $10.6, or 1.1%, to $942.3, including a $25.1, or 2.7%, favorable impact from currency movements, as compared to the prior period. Organic net sales decreased $14.5, or 1.6%. Organic sales in North America declined 2.6% driven primarily by lower volumes in Wet Shave and Skin Care, partially offset by volume growth in Grooming and Sun Care. Organic sales in International markets declined 0.3%, largely driven by lower volumes in Sun Care and Grooming, partially offset by favorable pricing in Wet Shave.

Current wording

•Net sales for the first nine months of fiscal 2026 increased $20.3, or 1.4%, to $1,512.4, including a $28.7, or 2.0% favorable impact due to currency movements. Organic net sales decreased $8.4, or 0.6%. Organic sales in North America declined 0.4% driven primarily by lower volumes in Wet Shave and Skin Care, partially offset by volume growth in Grooming and Sun Care. Organic sales in International markets declined 0.7% largely driven by lower volumes in Sun Care, partially offset by favorable pricing in Wet Shave.

Previous wording

•Net (loss) earnings from continuing operations in the first six months of fiscal 2026 were $(25.2), as compared to $10.7 in the prior year period. On an adjusted basis, net earnings from continuing operations for the second quarter of fiscal 2026 were $20.2, as compared to $28.2 in the prior year period. Adjusted net earnings decreased primarily due to lower gross profit and higher operating expenses, partially offset by higher sales and lower interest expense.

Current wording

•Net earnings (loss) from continuing operations for the first nine months of fiscal 2026 decreased $45.0, or 140.2%, to $(12.9). On an adjusted basis, net earnings from continuing operations for the first nine months of fiscal 2026 decreased $8.2, or 13.2%, to $53.7. Adjusted net earnings from continuing operations decreased primarily due to lower gross profit and higher operating expenses, partially offset by higher sales and lower interest expense.

Previous wording

•Diluted net (loss) earnings per share from continuing operations during the first six months of fiscal 2026 were $(0.54), as compared to $0.22 in the prior year period. On an adjusted basis, diluted net earnings per share from continuing operations during the first six months of fiscal 2026 were $0.44, as compared to $0.59 in the prior year period.

Current wording

•Diluted net earnings (loss) per share from continuing operations during the first nine months of fiscal 2026 was $(0.28) compared to $0.67 in the prior year period. On an adjusted basis, as illustrated in the table below, net earnings per diluted share from continuing operations during the first nine months of fiscal 2026 were $1.15 compared to $1.28 in the prior year period.

Previous wording

The following table presents changes in net sales for the first six months and second quarter of fiscal 2026, as compared to the corresponding periods in fiscal 2025, and provides a reconciliation of organic net sales to reported amounts.

Current wording

The following table presents changes in net sales for the third quarter and first nine months of fiscal 2026, as compared to the corresponding periods in fiscal 2025, and provides a reconciliation of organic net sales to reported amounts.

Previous wording

•Net salesin the first six months of fiscal 2026 increased $10.6, or 1.1%, to $942.3, as compared to the prior year period. Organic net sales decreased $14.5, or 1.6%. Organic sales in North America declined 2.6% driven primarily by lower volumes in Wet Shave and Skin Care, partially offset by volume growth in Grooming and Sun Care. Organic sales in International markets declined 0.3% largely driven by lower volumes in Sun Care and Grooming, partially offset by favorable pricing in Wet Shave.

Current wording

For the first nine months of fiscal 2026, net sales were $1,512.4, an increase of $20.3, or 1.4%, including a $28.7, or 2.0%, favorable impact from currency movements. Organic net sales increased $8.4, or 0.6%. Organic sales in North America declined 0.4% driven primarily by lower volumes in Wet Shave and Skin Care, partially offset by volume growth in Grooming and Sun Care. Organic sales in International markets declined 0.7% largely driven by lower volumes in Sun Care, partially offset by favorable pricing in Wet Shave.

Previous wording

Gross profit was $216.9 during the second quarter of fiscal 2026, compared to $236.9 in the prior year quarter, a decrease of $20.0, or 8.4%. Gross margin as a percent of net sales for the second quarter of fiscal 2026 decreased 410-basis points, to 41.8%. Adjusted gross margin, as a percent of net sales, decreased 310-basis points to 43.4% in the quarter. Productivity savings of approximately 220-basis points were more than offset by 420-basis points of core inflation and tariffs, 70-basis points of unfavorable mix and promotional levels (net of pricing), and 40-basis points of unfavorable currency movements.

Current wording

Gross profit was $242.5 during the third quarter of fiscal 2026, compared to $250.1 in the prior year quarter, a decrease of $7.6, or 3.0%. Gross margin as a percent of net sales for the third quarter of fiscal 2026 decreased 210-basis points, to 42.5%. Adjusted gross margin, as a percent of net sales, decreased 30-basis points. Productivity savings of approximately 200-basis points and 40-basis points of favorable currency movements were more than offset by 160-basis points of core inflation and net tariffs and 110-basis points of unfavorable mix and promotional levels (net of pricing).

Previous wording

Gross profit was $377.9 during the first six months of fiscal 2026, compared to $409.4 in the prior year period, a decrease of $31.5, or 7.7%. Gross margin as a percent of net sales for the first six months of fiscal 2026 decreased 380-basis points, to 40.1%. Adjusted gross margin, as a percent of net sales, decreased 270-basis points. Productivity savings of approximately 230-basis points were more than offset by approximately 430-basis points of core inflation, tariffs, and volume absorption and 75-basis points of unfavorable mix and promotional levels (net of pricing).

Current wording

Gross profit was $620.4 during the first nine months of fiscal 2026, compared to $659.4 in the prior year period, a decrease of $39.0, or 5.9%. Gross margin as a percent of net sales for the first nine months of fiscal 2026 decreased 320-basis points, to 41.0%. Adjusted gross margin as a percent of net sales decreased 180-basis points, to 42.7%. Productivity savings of approximately 220-basis points and 20-basis points of favorable foreign currency were more than offset by 320-basis points of core inflation, volume absorption and net tariffs and 100-basis points of unfavorable mix and promotional levels (net of pricing).

Previous wording

Selling, general and administrative (“SG&A”) expense was $111.0, or 21.4%, of net sales in the second quarter of fiscal 2026 compared to $102.8, or 19.9%, of net sales in the prior year quarter. Adjusted SG&A was 20.1% of net sales, compared to 19.6% in the prior year quarter, which was primarily driven by higher consulting and corporate expenses and unfavorable currency impacts, partly offset by lower people costs.

Current wording

Selling, general and administrative (“SG&A”) expense was $108.3, or 19.0%, of net sales in the third quarter of fiscal 2026 compared to $100.7, or 18.0%, of net sales in the prior year quarter. Adjusted SG&A was 18.4% of net sales, compared to 17.6% in the prior year quarter, which was primarily driven by higher incentive compensation expense and unfavorable currency impacts in the current year, partly offset by lower people and consulting expenses.

Previous wording

Selling, general and administrative (“SG&A”) expense was $213.4, or 22.6%, of net sales in the first six months of fiscal 2026 compared to $202.4, or 21.7%, of net sales in the prior year period. Adjusted SG&A was 21.7% of net sales, compared to 21.4% in the prior year quarter, which was primarily driven by higher outside services costs and corporate expenses, partially offset by lower people costs.

Current wording

SG&A expense was $321.7, or 21.3%, of net sales in the first nine months of fiscal 2026 compared to $303.1, or 20.3%, of net sales in the prior year period. Adjusted SG&A was $309.5, or 20.5% of net sales, an increase of 50-basis points, which was primarily driven by higher incentive compensation expense and higher consulting expenses.

Previous wording

Advertising and sales promotion (“A&P”) expense for the second quarter of fiscal 2026 was $58.6, a decrease of $1.3, or 2.2%, compared to $59.9 in the prior year quarter. A&P was 11.3% of net sales, compared to 11.6% in the prior year quarter.

Current wording

Advertising and sales promotion (“A&P”) expense for the third quarter of fiscal 2026 was $83.2, an increase of $7.2, or 9.5%, compared to $76.0 in the prior year quarter. A&P was 14.6% of net sales, compared to 13.6% in the prior year quarter.

Previous wording

Advertising and sales promotion (“A&P”) expense for the first six months of fiscal 2026 was $104.2, a decrease of $1.8, or 1.7%, compared to $106.0 in the prior year period. A&P was 11.1% of net sales, compared to 11.4% in the prior year quarter.

Current wording

A&P expense for the first nine months of fiscal 2026 was $187.4, an increase of $5.4, or 3.0%, compared to $182.0 in the prior year period. A&P was 12.4% of net sales, compared to 12.2% in the prior year period.

Previous wording

Research and development (“R&D”) expense for the second quarter of fiscal 2026 was $14.9, an increase of $1.5, or 11.2%, compared to $13.4 in the prior year quarter. As a percentage of net sales, R&D expense was 2.9% in the second quarter of fiscal 2026, compared to 2.6% in the prior year quarter.

Current wording

Research and development (“R&D”) expense for the third quarter of fiscal 2026 was $13.3, a decrease of $0.2, or 1.5%, compared to $13.5 in the prior year quarter. As a percentage of net sales, R&D expense was 2.3% in the third quarter of fiscal 2026, compared to 2.4% in the prior year quarter.

Previous wording

Research and development (“R&D”) expense for the first six months of fiscal 2026 was $28.7, an increase of $1.9, or 7.1%, compared to $26.8 in the prior year period. As a percentage of net sales, R&D expense was 3.0% in the first six months of fiscal 2026, compared to 2.9% in the prior year period.

Current wording

R&D expense for the first nine months of fiscal 2026 was $42.0, an increase of $1.8, or 4.5%, compared to $40.2 in the prior year period. As a percentage of net sales, R&D expense was 2.8% in the first nine months of fiscal 2026, compared to 2.7% in the prior year period.

Previous wording

In fiscal 2026, the Company continues to take specific actions to strengthen its operating model, simplify the organization and improve manufacturing and supply chain efficiency through restructuring actions, including streamlining the Company’s operations and supply chain by consolidating its Mexico facilities and Wet Shave operations. As a result of these actions, we expect to incur pre-tax charges of approximately $90 in fiscal 2026. We incurred $14.0 and $11.8 of restructuring and related charges in the second quarter of fiscal 2026 and 2025, respectively, and $32.1 and $15.9 during the first six months of fiscal 2026 and 2025, respectively.

Current wording

In fiscal 2026, the Company continues to take specific actions to strengthen its operating model, simplify the organization and improve manufacturing and supply chain efficiency through restructuring actions, including streamlining the Company’s operations and supply chain by consolidating its Mexico facilities and Wet Shave operations. As a result of these actions, we expect to incur pre-tax charges of approximately $92 in fiscal 2026. We incurred $12.7 and $14.9 during the third quarter of fiscal 2026 and 2025, respectively, and $44.8 and $30.9 during the first nine months of fiscal 2026 and 2025, respectively.

Previous wording

Other restructuring related charges of $8.7 and $14.5 associated with the consolidation of Wet Shave operations and supply chain actions were recorded in costs of products sold in the second quarter and first six months of fiscal 2026, respectively, and $0.3 and $0.8 were recorded in selling, general and administrative expense in the second quarter and first six months of fiscal 2026, respectively. No charges were incurred in the comparative prior period in costs of products sold and SG&A related to these actions.

Current wording

Other restructuring related charges of $11.2 and $25.7 were recorded in costs of products sold in the third quarter and first nine months of fiscal 2026, respectively, and $0.6 and $1.4 were recorded in selling, general and administrative expense in the third quarter and first nine months of fiscal 2026, respectively. Other restructuring related charges of $1.2 was recorded in costs of products sold in both the third quarter and first nine months of fiscal 2025 and $0.6 was recorded in selling, general and administrative expense in both the third quarter and first nine months of fiscal 2025.

Previous wording

Interest expense associated with debt for the second quarter of fiscal 2026 was $17.9, a decrease of $2.3, or 11.4%, compared to $20.2 in the prior year quarter. The decrease in interest expense was the result of lower borrowing levels on the Company’s U.S. Revolving Credit Facility as a result of the paydown of the revolving credit facility utilizing cash proceeds from the divestiture of the Feminine Care business.

Current wording

Interest expense associated with debt for the third quarter of fiscal 2026 was $16.7, a decrease of $2.7, or 13.9%, compared to $19.4 in the prior year quarter. The decrease in interest expense was the result of lower borrowing levels on the Company’s Revolving Credit Facility due to the paydown of the facility with the proceeds from the Feminine Care divestiture.

Previous wording

Interest expense associated with debt for the first six months of fiscal 2026 was $37.2, a decrease of $1.8, or 4.6%, compared to $39.0 in the prior year period. The decrease in interest expense was the result of lower borrowing levels on the Company’s U.S. Revolving Credit Facility as a result of the paydown of the revolving credit facility utilizing cash proceeds from the divestiture of the Feminine Care business.

Current wording

Interest expense associated with debt for the first nine months of fiscal 2026 was $53.9, a decrease of $4.5, or 7.7%, compared to $58.4 in the prior year period. The decrease in interest expense was the result of lower borrowing levels on the Company’s Revolving Credit Facility due to the paydown of the facility with the proceeds from the Feminine Care divestiture.

Previous wording

Other (income) expense, net, $(7.4) compared to $(2.6) in the prior year quarter. The current year quarter included $6.7 of Transition Services Agreement (“TSA”) income. Additionally, the current year quarter included $0.2 of other project gains, compared to $0.6 in the prior year quarter. Currency hedge and remeasurement losses were $0.9 in the current quarter, compared to gains of $2.4 in the prior year quarter. Adjusted other (income) expense, net was $(7.2) compared to $(2.0) in the prior year quarter.

Current wording

Other (income) expense, net, was income of $9.7 in the third quarter of fiscal 2026, compared to income of $2.9 in the prior year quarter. The current year quarter included $7.7 million of Transition Services Agreement (“TSA”) income and the prior year quarter included $2.7 of other project gains. Currency hedge and remeasurements gains were $0.6 million in the current quarter, compared to a gain of $1.1 million in the prior year quarter. Adjusted other (income) expense, net was $(9.7) compared to $(0.2) in the prior year quarter.

Previous wording

Other (income) expense, net, was $(8.7) compared to $0.6 in the prior year period. The current year quarter included $6.7 of TSA income. Currency hedge and remeasurement losses were $1.7 in the current period, compared to gains of $0.4 in the prior year period. The current year period included $0.7 of other project gains, compared to $1.2 of expense in the prior year quarter. Adjusted other (income) expense, net was $(6.5) compared to $0.3 in the prior year period.

Current wording

Other (income) expense, net, was income of $18.4 in the first nine months of fiscal 2026 compared to income of $2.3 in the prior year period. The first nine months of fiscal 2026 included $14.4 of TSA income and the prior year period included $1.5 of other project gains. Currency hedge and remeasurements losses were $1.1 million in the current period, compared to a gain of $1.4 million in the prior year period. Adjusted other (income) expense, net was $(16.2) compared to $0.1 in the prior year period.

Previous wording

The continuing operations effective tax rate for the second quarter of fiscal 2026, was 49.7%, as compared to 33.7% in the prior year quarter. The fiscal 2026 effective tax rate reflects more unusual items resulting in larger tax expense compared to fiscal 2025. On an adjusted basis, the effective tax rate was 27.9%, down from the prior year quarter adjusted effective tax rate of 30.9%.

Current wording

The continuing operations effective tax rate for the third quarter of fiscal 2026, was 31.5%, compared to 24.5% in the prior year quarter. The fiscal 2026 effective tax rate reflects an unfavorable mix of earnings in higher tax rate jurisdictions and more unusual items resulting in a larger tax expense compared to fiscal 2025. On an adjusted basis, the effective tax rate was 27.2% for the third quarter of fiscal 2026, and 24.3% in the prior year quarter.

Previous wording

The continuing operations effective tax rate for the first six months of fiscal 2026, was 13.1%, as compared to 42.6% in the prior year period. The current year period reflects a tax benefit on a loss. The fiscal 2026 effective tax rate reflects more favorable discrete and unusual items resulting in a tax benefit compared to fiscal 2025. On an adjusted basis, the effective tax rate was 24.9% down from the prior year period adjusted effective tax rate of 33.6%.

Current wording

The continuing operations effective tax rate for the first nine months of fiscal 2026, was (17.0)%, as compared to 31.7% in the prior year period. The current year period reflects a tax expense on a loss. The fiscal 2026 effective tax rate reflects more favorable discrete and unusual items compared to fiscal 2025. On an adjusted basis, the effective tax rate was 26.3% down from the prior year period adjusted effective tax rate of 28.8%.

Previous wording

(Loss) earnings from discontinued operations, net of tax

Current wording

Earnings (loss) from discontinued operations, net of tax

Previous wording

(Loss) earnings from discontinued operations, net of tax includes the results of the Feminine Care business.

Current wording

Earnings (loss) from discontinued operations, net of tax includes the results of the Feminine Care business.

Previous wording

The loss of $14.6 in the second quarter of fiscal 2026 primarily includes the impact of tax related charges from the completion of the Feminine Care Divestiture. The loss of $51.1 in the first six months of 2026 also includes the impact of the goodwill impairment charge of $37.4 recorded during the first quarter.

Current wording

The income of $1.4 in the third quarter of fiscal 2026 primarily includes the impact of tax related charges from the completion of the Feminine Care divestiture. The loss of $49.7 in the first nine months of 2026 also includes the impact of the goodwill impairment charge of $37.4 recorded during the first quarter of fiscal 2026.

Previous wording

The following tables present changes in segment net sales and segment profit for the second quarter and first six months of fiscal 2026, compared to the corresponding period in fiscal 2025, and provide a reconciliation of organic segment net sales and organic segment profit to reported amounts. For a reconciliation of segment profit to Income (loss) from continuing operations before income taxes, refer to Note 17 of Notes to Condensed Consolidated Financial Statements.

Current wording

The following tables present changes in segment net sales and segment profit for the third quarter and first nine months of fiscal 2026, compared to the corresponding period in fiscal 2025, and provide a reconciliation of organic segment net sales and organic segment profit to reported amounts. For a reconciliation of segment profit to Earnings (loss) from continuing operations before income taxes, refer to Note 18 of Notes to Condensed Consolidated Financial Statements.

Previous wording

Wet Shave segment profit for the first six months was $75.9, a decrease of $17.3, or 18.6%, and inclusive of a $3.4, or 3.6%, favorable impact from currency. Organic segment profit decreased $20.7, or 22.2%, as lower gross margins and higher SG&A expense were primarily offset by lower marketing expenses.

Current wording

Wet Shave segment profit for the first nine months of fiscal 2026 was $106.0, a decrease of $31.3, or 22.8%, and inclusive of a $5.1, or 3.7%, favorable impact from currency. Organic segment profit decreased $36.4, or 26.5%, due to lower gross margin and higher SG&A.

Previous wording

During the second quarter and first six months of fiscal 2026, we recorded TSA income of $6.7 in Interest and other expense, net.

Current wording

During the third quarter and first nine months of fiscal 2026, we recorded TSA income of $7.7 and $14.4 in Interest and other expense, net.

Previous wording

During the second quarter of fiscal 2026, we recorded a charge of $4.7 related to legal matters.

Current wording

During the first nine months of fiscal 2026, we recorded charges of $5.7 related to legal matters.

Previous wording

During the first six months of fiscal 2026 and 2025, we recorded a gain of $1.5 and $0.9, respectively, for the fair value measurement of certain equity interests accounted for under the cost and equity methods.

Current wording

During the first nine months of fiscal 2026 and 2025, we recorded gains of $1.5 of $0.9, respectively, for the fair value measurement of an equity method investment.

Previous wording

As of March 31, 2026, a significant portion of our cash balances was located outside the U.S. Given our extensive international operations, a significant portion of our cash is denominated in foreign currencies. Refer to Note 16 of Notes to Condensed Consolidated Financial Statements for a discussion of the primary currencies to which the Company is exposed. We manage our worldwide cash requirements by reviewing available funds among the many subsidiaries through which we conduct business and the cost effectiveness with which those funds can be accessed. We generally repatriate a portion of current year earnings from select non-U.S. subsidiaries only if the economic cost of the repatriation is not considered material.

Current wording

At June 30, 2026, we had cash of $397.1, a significant portion of which was located outside the U.S. Given our extensive international operations, a significant portion of our cash is denominated in foreign currencies. Refer to Note 16 of Notes to Condensed Consolidated Financial Statements for a discussion of the primary currencies to which the Company is exposed. We manage our worldwide cash requirements by reviewing available funds among the many subsidiaries through which we conduct business and the cost effectiveness with which those funds can be accessed. We generally repatriate a portion of current year earnings from select non-U.S. subsidiaries only if the economic cost of the repatriation is not considered material.

Previous wording

Historically, we have generated, and expect to continue to generate, favorable cash flows from operations. Our cash flows are affected by the seasonality of our Sun Care businesses, typically resulting in higher net sales and increased cash generated in the second and third quarters of each fiscal year. We believe our cash on hand, including remaining proceeds from the sale of our Feminine Care segment, cash flows from operations and borrowing capacity under the U.S. Revolving Credit Facility will be sufficient to satisfy our future working capital requirements, interest payments, R&D activities, capital expenditures, and other capital requirements for at least the next 12 months. We will continue to monitor our cash flows, spending and liquidity needs. For more information on the U.S. Revolving Credit Facility and our other debt, see Note 11 to the Notes To Condensed Consolidated Financial Statements and Note 12 of the Notes to Consolidated Financial Statements in our 2025 Annual Report.

Current wording

Historically, we have generated, and expect to continue to generate, favorable cash flows from operations. Our cash flows are affected by the seasonality of our Sun Care business, typically resulting in higher net sales and increased cash generated in the second and third quarter of each fiscal year. We believe our cash on hand, including remaining proceeds from the sale of our Feminine Care segment, cash flows from operations and borrowing capacity under the Revolving Credit Facility will be sufficient to satisfy our future working capital requirements, interest payments, R&D activities, capital expenditures, and other capital requirements for at least the next 12 months. We will continue to monitor our cash flows, spending and liquidity needs. For more information on the U.S. Revolving Credit Facility and our other debt, see Note 11 to the Notes To Condensed Consolidated Financial Statements and Note 13 of the Notes to Consolidated Financial Statements in our 2025 Annual Report.

Previous wording

A summary of our cash flow activities is provided in the following table:

Current wording

A summary of our cash flow from operating, investing and financing activities is provided in the following table:

Previous wording

Cash flow used for operating activities was $71.6 during the first six months of fiscal 2026, compared to $70.5 during the prior year period. The increase in cash used for operating activities was largely driven by lower earnings, partially offset by changes in net working capital.

Current wording

Cash flow provided by operating activities was $47.1 during the first nine months of fiscal 2026, as compared to $44.3 during the prior year period. The increase in cash provided by operating activities in the first nine months of fiscal 2026 was driven by changes in net working capital.

Previous wording

Net cash proceeds provided by investing activities was $315.1 during the first six months of fiscal 2026, compared to net cash used of $33.0 during the prior year period. The increase in cash provided by investing activities was primarily related to proceeds received from the sale of our Feminine Care segment of $338.9 and a decrease in capital expenditures, which were $25.6 during the first six months of fiscal 2026, compared to $33.9 in the prior year period.

Current wording

Cash flow provided by investing activities was $301.0 during the first nine months of fiscal 2026 as compared to cash used for investing activities of $45.3 during the prior year period. The increase in cash provided by investing activities was primarily related to proceeds received from the sale of our Feminine Care segment of 338.9 and a decrease in capital expenditures which were $41.2 during the first nine months of fiscal 2026, compared to $49.4 in the prior year period.

Previous wording

Net cash used by financing activities was $167.4 during the first six months of fiscal 2026, compared to $72.5 cash provided by financing activities in the prior year period. During the first six months of fiscal 2026, we had net payments of $140.0 under the U.S. Revolving Credit Facility, compared to net proceeds of $157.0 in the prior year period. Dividend payments totaled $14.5 in the first six months of fiscal 2026, compared to $15.2 in the prior year period. We had $15.8 share repurchases in the first six months of fiscal 2026, compared to $65.7 in the prior year period.

Current wording

Net cash used for financing activities was $174.7 during the first nine months of fiscal 2026 as compared to $10.9 during the prior year period. During the first nine months of fiscal 2026, we had net payments of $140.0 under the Revolving Credit Facility, compared to net proceeds of $96.0 in the prior year period. Dividend payments totaled $21.5 during the first nine months of fiscal 2026, compared to $22.4 in the prior year period. We had $15.8 share repurchases in the first nine months of fiscal 2026, compared to $90.2 in the prior year period.